Statistics
The Exicure stock price is currently $ 1.08 with a total market cap valuation of $ 7.07M (6.55M shares outstanding). The Exicure is trading on NASDAQ under the ticker sign XCUR. Exicure price is up
Description
Exicure, Inc. is a biotechnology firm that utilizes its unique spherical nucleic acid (SNA) platform to create therapies for neurological conditions and hair loss. Its primary experimental candidate, SCN9A, is currently undergoing preclinical evaluation for addressing neuropathic and chronic pain. The company has entered into a strategic partnership with AbbVie Inc. to advance SNA-based solutions for various hair loss conditions, under a collaboration, option, and license agreement. Additionally, a separate collaborative effort with Ipsen S.A. aims to investigate, develop, and commercialize novel spherical nucleic acids targeting Huntington's disease and Angelman syndrome. Established in 2011, Exicure's corporate base is located in Chicago, Illinois.
Company Profile
- Full Name: Exicure
- Sector: Healthcare
- Website: https://www.exicuretx.com
